Hunt, Matthew A <br/><br/>
Caveats for triple-H therapy in the management of vasospasm after aneurysmal subarachnoid hemorrhage.  [electronic resource] 

 -  Critical care medicine  Aug 2007 
 - 1985-6 p.  digital 
<br/><br/> Publication Type: Comment; Editorial 
<br/><br/><label>ISSN: </label>0090-3493 
<br/><br/><label>Standard No.: </label>10.1097/01.CCM.0000277255.94441.78  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cerebrovascular Circulation--drug effects<br/>Hemodilution--adverse effects<br/>Humans<br/>Plasma Substitutes--adverse effects<br/>Subarachnoid Hemorrhage--therapy<br/>Vasoconstrictor Agents--adverse effects<br/>Vasospasm, Intracranial--therapy